Literature DB >> 9153564

Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases.

B Kovacs1, A Patel, J N Hershey, G J Dennis, M Kirschfink, G C Tsokos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9153564     DOI： 10.1002/art.1780400531

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.

Authors:  Takashi Himoto; Hirohito Yoneyama; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Reiji Haba; Seishiro Watanabe; Shoichi Senda; Tsutomu Masaki
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

3.  Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population.

Authors:  Jie Yang; Ji-Min Zhu; Song Wu; Jing Li; Ming-Rui Wang; Ting-Ting Wang; Yu-Wei Lu
Journal:  Rheumatol Int       Date:  2017-02-09       Impact factor: 2.631

4.  Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue.

Authors:  T Rème; A Travaglio; E Gueydon; L Adla; C Jorgensen; J Sany
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

6.  Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.

Authors:  R Chauhan; R Handa; T P Das; U Pati
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 7.  Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.

Authors:  Takashi Himoto; Mikio Nishioka
Journal:  Auto Immun Highlights       Date:  2013-02-22

Review 8.  The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target.

Authors:  Alessandra Fierabracci; Marsha Pellegrino
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

9.  Activation of innate immunity by mitochondrial dsRNA in mouse cells lacking p53 protein.

Authors:  Dagmara M Wiatrek; Maria E Candela; Jiří Sedmík; Jan Oppelt; Liam P Keegan; Mary A O'Connell
Journal:  RNA       Date:  2019-03-20       Impact factor: 4.942

10.  Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.

Authors:  Marsha Pellegrino; Gianandrea Traversi; Andrea Arena; Marco Cappa; M Manuela Rosado; Marco Andreani; Domenico V Delfino; Fabiola Moretti; Alessandra Fierabracci
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.